EFFECTS OF INTRAVENOUS IRON THERAPY IN IRON DEFICIENT PATIENTS WITH SYSTOLIC HEART FAILURE: META-ANALYSIS OF RANDOMIZED CONTROL TRIALS

2015 
Iron deficiency (ID) is an ominous co-morbidity commonly found in patients with systolic heart failure (HF), and iron therapy is presumed to bring clinical benefits. We performed a meta-analysis of all randomized control trials that compared the effects of intravenous iron therapy with either no
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []